NRXN2-AS1
Basic information
Region (hg38): 11:64646399-64659681
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (14 variants)
- not specified (13 variants)
- Inborn genetic diseases (11 variants)
- NRXN2-related condition (3 variants)
- NRXN2-associated Neurodevelopmental disorder (1 variants)
- Developmental and epileptic encephalopathy, 1 (1 variants)
- See cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NRXN2-AS1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 0 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 23 | 12 | 40 | |||
Total | 0 | 0 | 23 | 5 | 12 |
Variants in NRXN2-AS1
This is a list of pathogenic ClinVar variants found in the NRXN2-AS1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-64648218-C-T | NRXN2-related disorder | Uncertain significance (Aug 16, 2023) | ||
11-64648219-G-A | not specified | Likely benign (May 22, 2015) | ||
11-64648254-G-A | not specified | Uncertain significance (Feb 01, 2017) | ||
11-64648295-G-A | not specified • NRXN2-related disorder | Benign (Dec 04, 2020) | ||
11-64648431-C-T | Benign (Jun 20, 2021) | |||
11-64648559-C-A | Benign (Jun 21, 2021) | |||
11-64648761-T-C | Uncertain significance (Aug 18, 2021) | |||
11-64648763-C-A | not specified | Uncertain significance (Nov 07, 2022) | ||
11-64648763-C-T | NRXN2-associated Neurodevelopmental disorder | Uncertain significance (Feb 05, 2021) | ||
11-64648773-C-A | not specified | Uncertain significance (Jun 21, 2021) | ||
11-64648789-T-C | not specified | Uncertain significance (Oct 12, 2016) | ||
11-64648800-C-T | not specified | Uncertain significance (Oct 27, 2021) | ||
11-64648804-G-C | not specified • NRXN2-related disorder | Benign (Nov 13, 2015) | ||
11-64648841-C-T | Developmental and epileptic encephalopathy, 1 | Uncertain significance (Dec 17, 2018) | ||
11-64648884-T-C | not specified • NRXN2-related disorder | Likely benign (Dec 31, 2019) | ||
11-64650496-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
11-64650498-G-A | NRXN2-related disorder | Uncertain significance (Jun 10, 2023) | ||
11-64650520-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
11-64650787-T-C | Benign (Jun 19, 2021) | |||
11-64650833-G-A | Benign (Jun 19, 2021) | |||
11-64651249-C-T | not specified | Benign (Jun 25, 2019) | ||
11-64651268-C-T | not specified | Uncertain significance (May 17, 2023) | ||
11-64651290-G-A | not specified | Benign/Likely benign (Dec 31, 2019) | ||
11-64651428-G-A | not specified | Benign (Jun 22, 2018) | ||
11-64651435-C-T | not specified | Uncertain significance (Aug 02, 2022) |
GnomAD
Source:
dbNSFP
Source: